Magnesium Sulfate Obstetric Dosing & Toxicity Protocol (ACOG Preeclampsia / Eclampsia) Calculator | Clinical Interpretation & Formula

High Yield Prometric Topic•Obstetrics & Gynecology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like Magnesium Sulfate Obstetric Dosing & Toxicity Protocol (ACOG Preeclampsia / Eclampsia) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Practice Obstetrics & Gynecology MCQs Take Free Trial

Clinical Significance & Diagnostic Standard

2026 Clinical Reference

What is the Magnesium Sulfate Obstetric Dosing & Toxicity Protocol (ACOG Preeclampsia / Eclampsia)?

📋Clinical Summary & Definition Capsule

The Magnesium Sulfate Obstetric Dosing & Toxicity Protocol (ACOG Preeclampsia / Eclampsia) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in obstetrics & gynecology practice. Implements the American College of Obstetricians and Gynecologists (ACOG) and WHO guidelines for Magnesium Sulfate administration in severe preeclampsia, active eclampsia, and preterm fetal neuroprotection (< 32 weeks), monitoring therapeutic serum levels (4.8–8.4 mg/dL) and toxicity stages. Clinical scoring tools like Magnesium Sulfate Obstetric Dosing & Toxicity Protocol (ACOG Preeclampsia / Eclampsia) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

The definitive life-saving therapy reducing eclamptic seizure risk by > 50% and maternal mortality in severe preeclampsia.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate Magnesium Sulfate Obstetric Dosing & Toxicity Protocol (ACOG Preeclampsia / Eclampsia):

Loading Dose = 4.0–6.0 g IV over 15–20 min

Maintenance Infusion = 1.0–2.0 g/hour IV (1.0 g/hr if Cr > 1.0 or Urine < 30 mL/hr)

Therapeutic Serum Range: 4.8–8.4 mg/dL (2.0–3.5 mmol/L)

Antidote = 1.0 g IV Calcium Gluconate 10% (10 mL over 3–5 min)

Risk Stratification

Score Interpretation & Clinical Stratification

Score Range	Clinical Interpretation	Risk Tier
≤ 4.7	Subtherapeutic Level (< 4.8 mg/dL / Seizure Risk)	yellow
4.8 – 8.4	Therapeutic Range (4.8–8.4 mg/dL [2.0–3.5 mmol/L])	green
≥ 8.5	Toxic Hypermagnesemia (≥ 8.5 mg/dL / Stop Infusion / Give Calcium Gluconate)	red

Clinical Limitations & Contraindications

When to Exercise Caution

Contraindicated in myasthenia gravis (precipitates acute myasthenic crisis/respiratory arrest) and high-grade atrioventricular heart block.

Peer-Reviewed Medical Literature

•American College of Obstetricians and Gynecologists (ACOG). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-e260.
•World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011.
•The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877-1890.

Clinical Decision Network